Bayer MEDRAD Injector End of Life Dates and What They Mean
Bayer is retiring its legacy contrast injector platforms and pointing customers toward its current systems, the MEDRAD Stellant FLEX and Centargo for CT and the MEDRAD MRXperion for MR, and the MEDRAD Mark 7 Arterion for angiography. Those are capable machines and a sensible choice when new equipment fits the budget. Worth knowing as you plan: each of them runs its own consumable line, so the kits you stock today do not move with you. A qualified refurbished injector on the platform you already run is also a legitimate option, and your syringes, protocols and training all stay exactly as they are. If you operate a Stellant or a Spectris Solaris EP, an end-of-life date has already been published for your system. Here is what Bayer has announced, what it withdraws, and what your options actually are.
Published End of Life Dates
| Platform | End of life | Status |
|---|---|---|
| MEDRAD Stellant CT Injection Systems - Classic models, Dual and Single, and with Certegra Workstation | 12/31/2028 | Announced |
| MEDRAD Spectris Solaris EP MR Injection System and Solaris EP Mobile | 12/31/2028 | Announced |
| MEDRAD Mark V ProVis Injection System | 12/31/2025 | Passed |
| MEDRAD Spectris MR Injection System | 12/31/2024 | Passed |
| MEDRAD Spectris Solaris MR, Vistron CT, EnVision CT, MCT and MCT Plus, Mark V and Mark V Plus, Mark IV, Mark ProVis, Certegra Workstation 1.0, XDS Extravasation Detector, Intego PET 100 | Already discontinued, end-of-life letters published by Bayer | |
Source: Bayer Radiology, Product Lifecycle Announcements. Dates verified against Bayer's published end of life letters on 2026-09-30. Confirm against Bayer's current page before making a purchasing decision.
Compiled by FDM Enterprises | 615-479-5572 | fdmenterprises.com
Where Stellant and Solaris EP Owners Are Right Now
Bayer’s end of life letters set out three steps, not one date. On both the Stellant CT and the Spectris Solaris EP, Bayer wrote: "You have from now until December 31, 2025 to renew coverage for a final year of full-service support." Then: "After that one year contract ends, you have several limited service options to maintain the equipment while planning for your upgrade." End of life itself is 12/31/2028.
That renewal window has closed. If your department renewed, you are somewhere inside that final year of Bayer full service now. If you did not, you are already into Bayer’s limited service options. Either way, the date that affects you is not 2028.
An independent service organization is a legitimate alternative at that point. We carry preventive maintenance, calibration verification and repair on the Stellant and the Spectris Solaris, and we supply equivalent replacement kits for those and for platforms Bayer has already discontinued. Bayer’s own letters are linked in the questions below, so you can check all of this rather than take our word for it. Injector service and support.
What an End of Life Date Withdraws
Bayer states that after the end-of-life date it will no longer offer service, including preventive maintenance, equipment calibration, replacement parts and technical support, or consumables for that installed base. In practice that is five separate problems arriving on the same day:
No preventive maintenance
Your annual PM has to come from somewhere else, and accreditation and risk-management programs still expect documented maintenance on injection equipment.
No calibration
Flow rate and volume verification still need performing and documenting.
No replacement parts
Component failures move to third-party stock and repair rather than replacement.
No technical support
No factory line when the head faults mid-shift.
No consumables
The one departments underestimate. Bayer has already discontinued the SQK 65VS, CTP-200-FLS, 150-FT-Q and 200-FT-Q kits.
We are not going to tell you to replace working equipment. If a unit is beyond economical repair we will say so, and we also buy used imaging equipment and sell refurbished injectors when you retire one. And if you are letting one go rather than replacing it, what a used injector is worth sets out what we pay and why.
Running One of These?
We service Stellant and Spectris Solaris, and we supply the consumables for them, including platforms Bayer has already discontinued. Call 615-479-5572. Syringe kits.
Frequently Asked Questions
You buy equivalent kits. Bayer has discontinued the CTP-200-FLS, SQK 65VS, 150-FT-Q and 200-FT-Q. We supply replacements for all four, by the case, shipped from the manufacturer's US warehouse.
This is not something coming in 2028. Bayer ended support for the EnVision on 12/31/2023, and for the Vistron, the Mark V ProVis and the non-EP Spectris Solaris on 12/31/2025. Those kits are already gone. The injectors still work.
Tell us the part number on the box you used to order and we will tell you which of ours replaces it. Call 615-479-5572 or use the cross reference.
Bayer moves you to its limited service options until the 12/31/2028 end of life. You do not have to stay with Bayer for that. An independent can carry the preventive maintenance, calibration verification and repair, and equivalent replacement kits are available for the Stellant and the Spectris Solaris. Call 615-479-5572.
Independent service organizations do. We service the Stellant and Spectris Solaris across the central and southeastern US, including platforms Bayer has already retired, and we supply the consumables for them. See Injector service and support.
Bayer has published 12/31/2028 for the Stellant CT Injection Systems, covering the Classic models, the Dual and Single models, and the version with the Certegra Workstation.
Yes, 12/31/2028. The earlier non-EP Spectris Solaris and the original Spectris are already discontinued.
End of life is a support decision, not a safety recall. What matters is that preventive maintenance and calibration verification continue to be performed and documented by a qualified provider.
Not from Bayer for that platform. FDA-cleared compatible kits are manufactured for all of these systems and we supply them. See the syringe cross reference.
No. Those are Bayer's upgrade paths, not a requirement. Independent service and compatible consumables are a legitimate alternative for a system that still performs.
It depends on the unit and how it has been maintained. A preventive maintenance visit and an honest inspection will tell you far more than a date on a letter.
SQK 65VS, CTP-200-FLS, 150-FT-Q and 200-FT-Q.
We would rather you checked this against the source than took our word for it. These are Bayer's published documents.
- Bayer Radiology: Discontinued Products and Product Lifecycle Announcements
- MEDRAD Stellant CT Injection Systems, end of life letter (PDF)
- MEDRAD Spectris Solaris EP MR Injection System, end of life letter (PDF)
- MEDRAD Mark V ProVis Injection System, end of life letter (PDF)
- MEDRAD Spectris MR Injection System, end of life letter (PDF)
- MEDRAD Mark V and Mark V Plus Injection Systems, end of life letter (PDF)
- MEDRAD Certegra Workstation 1.0, end of life notification (PDF)
Tell Us What You Run
Request a quote
We reply by the next business day.
Our Other Injector Services
Service Coverage
FDM Enterprises provides MRI, CT and contrast injector service, repair and calibration across the central and southeastern US.